Compositions and methods for preventing and treating coronavirus infection--SARS-CoV-2 vaccines | Patent Publication Number 20210246170
US 20210246170 A1Patent NumberUS 11498944 B2
Application Number17163357
Filled DateJan 30, 2021
Priority DateJan 31, 2020
Publication DateAug 12, 2021
Original AssigneeJohnson & Johnson
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsLucy RUTTEN
Rinke BOS
An Vandebosch
Mark Johannes Gerardus Bakkers
David Adrianus Theodorus Maria Zuijdgeest
David Adrianus Theodorus Maria ZUIJDGEEST
Mathieu Claude Michel le GARS
Johannes Petrus Maria Langedijk
An VANDEBOSCH
Dan H. BAROUCH
Mark Johannes Gerardus BAKKERS
Frank WEGMANN
Dan H. Barouch
Mathieu Claude Michel Le Gars
Jerald C. Sadoff
Johannes Petrus Maria LANGEDIJK
Frank Wegmann
Jerald C. SADOFF
Lucy Rutten
Rinke Bos
Rinke BOS
An Vandebosch
Mark Johannes Gerardus Bakkers
David Adrianus Theodorus Maria Zuijdgeest
David Adrianus Theodorus Maria ZUIJDGEEST
Mathieu Claude Michel le GARS
Johannes Petrus Maria Langedijk
An VANDEBOSCH
Dan H. BAROUCH
Mark Johannes Gerardus BAKKERS
Frank WEGMANN
Dan H. Barouch
Mathieu Claude Michel Le Gars
Jerald C. Sadoff
Johannes Petrus Maria LANGEDIJK
Frank Wegmann
Jerald C. SADOFF
Lucy Rutten
Rinke Bos
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.